Health
Paranoia, Turmoil and Backlash: Inside the FDA Under Marty Makary
Insiders say one more high-profile misstep could put the commissioner’s job in jeopardy.
Food and Drug Administration Commissioner Marty Makary was supposed to be one of President Donald Trump’s more conventional, qualified personnel picks, with sterling academic credentials and bipartisan support.
But just over a year into his tenure, those inside the agency that regulates roughly one-fifth of consumer spending in the US describe a culture rocked by staff clashes, leadership turmoil, industry backlash and an embattled, paranoid leader. Outside, drug companies say they’ve been blindsided by setbacks.